skip to Main Content
PanCAN chief science officer Lynn Matrisian

Tumor Biology Matters

Dr. Lynn Matrisian of PanCAN, explains that molecular profiling of a pancreatic cancer patient's tumor can show which treatment will work best.
Brigitte Regnier and her husband read a book together while seated on a sofa.

Picking the Right Team

Brigitte Régnier found a treatment team that was using an unusual approach of giving chemoradiation before surgery for pancreatic cancer.
Dr. Luis Diaz, pancreatic cancer researcher

An Immunotherapy Game Changer

Immunotherapy with Keytruda (pembrolizumab) is approved for use in cancer patients with certain genetic defects in their tumors.
Back To Top